Inactive Instrument

Other languages IR-Med Inc. Other OTC

Equities

IRME

US46265R1032

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries	Apr. 05
IR-Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01
IR-Med Inc. and I.R Med Ltd. Appoints Aharon Klein as Interim Chief Executive Officer	Mar. 05
IR-Med Inc. Announces Cessation of Tzur Di-Cori Pursuant as Chief Executive Officer	Feb. 28
IR-Med Inc. Announces Resignation of Inna Martin as Director	Feb. 23
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe? Device at NPIAP 2024 Annual Conference on February 16	Feb. 13
IR-Med Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
IR-MED Announces Executive Changes Effective as of October 15, 2023	23-10-04
Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024	23-09-26
IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board	23-09-13
IR-Med Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe	23-07-17
IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board	23-06-07
IR-Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
IR-Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29
IR-Med Inc. Auditor Raises 'Going Concern' Doubt	23-03-28
IR-Med Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
IR-Med Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
IR-Med, Inc. Announces Resignation of David Lazar to Its Board of Directors	22-07-01
IR-Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages IR-Med Inc. Other OTC

Equities

IRME

US46265R1032

Other languages

Filters